Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Filings indexed 280 across all filing types
Latest filing 2025-05-02 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-02 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchange about an upcoming Board Meeting scheduled to declare the audited financial results for the fiscal period ended 31st March 2025. It is an intimation or announcement of the meeting and the forthcoming financial results, not the financial results report itself. The document is short (1443 characters) and serves as a regulatory announcement under SEBI regulations. Therefore, it is best classified as a Regulatory Filing (RNS) rather than an Annual Report (10-K) or Earnings Release (ER).
2025-05-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the closure of the trading window for dealing in the company's securities. It specifies the dates of closure related to the period ending 31st March 2025 and references compliance with SEBI regulations on insider trading. There is no financial data, report, or detailed analysis present. The document is an announcement related to trading restrictions rather than a financial report or regulatory filing about financial results or corporate governance changes. Given the content and length (1465 characters), it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-03-28 English
Outcome of Board Meeting
Regulatory Filings
2025-02-12 English
Financial Result Updates
Regulatory Filings
2025-02-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.